载脂蛋白E在致密沉积物中富集并可作为C3肾小球病中致密沉积物病的标志物
该研究对12例致密沉积物病(DDD)、12例C3肾小球肾炎(C3GN)和12例移植前对照肾活检组织进行激光显微切割联合质谱分析,发现DDD中C5-9和载脂蛋白E(ApoE)较C3GN显著增加,ApoE免疫组化可辅助诊断DDD。
要点
- DDD中C5-9较C3GN增加6-9倍,提示终末补体途径负担更重。
- DDD中ApoE较C3GN增加9倍,免疫组化可镜像致密沉积物。
- ApoE染色联合电镜诊断DDD,在无电镜时可能有用。
核心结论
- DDD的致密沉积物中ApoE富集,ApoE染色可作为电镜的辅助手段用于诊断DDD。
研究设计与样本
- 对12例DDD、12例C3GN和12例移植前对照肾活检组织进行激光显微切割联合质谱分析。
- 用31例C3G病例进行验证研究,基于ApoE染色确认C3GN和DDD诊断的符合率为80.6%。
主要发现
- 与对照相比,C3GN和DDD中补体蛋白C3、C5、C6、C7、C8、C9及调节蛋白CFHR5、CFHR1、CFH明显积累。
- C3、CFH和CFHR蛋白在C3GN和DDD中相当。
- DDD中C5-9较C3GN增加6至9倍。
- DDD中ApoE较C3GN增加9倍。
- ApoE免疫组化和共聚焦染色在DDD中镜像GBM致密沉积物染色,而在C3GN或对照中无此现象。
关键数值与推荐
- 验证研究中31例C3G病例基于ApoE染色诊断C3GN和DDD的符合率为80.6%。
临床怎么用
- ApoE染色可作为电镜的辅助手段用于诊断DDD,在电镜不可用时可能具有价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
C3 glomerulopathy (C3G) is a rare disease resulting from dysregulation of the alternative pathway of complement. C3G includes C3 glomerulonephritis (C3GN) and dense deposit disease (DDD), both of which are characterized by bright glomerular C3 staining on immunofluorescence studies. However, on electron microscopy (EM), DDD is characterized by dense osmiophilic mesangial and intramembranous deposits along the glomerular basement membranes (GBM), while the deposits of C3GN are not dense. Why the deposits appear dense in DDD and not in C3GN is not known. We performed laser microdissection (LCM) of glomeruli followed by mass spectrometry (MS) in 12 cases each of DDD, C3GN, and pretransplant kidney control biopsies. LCM/MS showed marked accumulation of complement proteins C3, C5, C6, C7, C8, C9 and complement regulating proteins CFHR5, CFHR1, and CFH in C3GN and DDD compared to controls. C3, CFH and CFHR proteins were comparable in C3GN and DDD. Yet, there were significant differences. First, there was a six-to-nine-fold increase of C5-9 in DDD compared to C3GN. Secondly, an unexpected finding was a nine-fold increase in apolipoprotein E (ApoE) in DDD compared to C3GN. Most importantly, immunohistochemical and confocal staining for ApoE mirrored the dense deposit staining in the GBM in DDD but not in C3GN or control cases. Validation studies using 31 C3G cases confirmed the diagnosis of C3GN and DDD in 80.6 % based on ApoE staining. Overall, there is a higher burden of terminal complement pathway proteins in DDD compared to C3GN. Thus, our study shows that dense deposits in DDD are enriched with ApoE compared to C3GN and control cases. Hence, ApoE staining may be used as an adjunct to EM for the diagnosis of DDD and might be valuable when EM is not available.
引用
- Madden B, Singh RD, Haas M, et al. Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy. Kidney Int. 2024. PMID: 38447879. doi:10.1016/j.kint.2024.02.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。